Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phyllanthus niruri as a promising alternative treatment for nephrolithiasis.
Boim MA, Heilberg IP, Schor N. Boim MA, et al. Among authors: heilberg ip. Int Braz J Urol. 2010 Nov-Dec;36(6):657-64; discussion 664. doi: 10.1590/s1677-55382010000600002. Int Braz J Urol. 2010. PMID: 21176271 Review.
Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia.
Heilberg IP, Martini LA, Teixeira SH, Szejnfeld VL, Carvalho AB, Lobão R, Draibe SA. Heilberg IP, et al. Nephron. 1998 Aug;79(4):430-7. doi: 10.1159/000045089. Nephron. 1998. PMID: 9689159 Clinical Trial.
Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients.
Baxmann AC, De O G Mendonça C, Heilberg IP. Baxmann AC, et al. Among authors: heilberg ip. Kidney Int. 2003 Mar;63(3):1066-71. doi: 10.1046/j.1523-1755.2003.00815.x. Kidney Int. 2003. PMID: 12631089 Clinical Trial.
Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.
Nishiura JL, Campos AH, Boim MA, Heilberg IP, Schor N. Nishiura JL, et al. Among authors: heilberg ip. Urol Res. 2004 Oct;32(5):362-6. doi: 10.1007/s00240-004-0432-8. Epub 2004 Jun 19. Urol Res. 2004. PMID: 15221244 Clinical Trial.
Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion.
Ferraz RR, Tiselius HG, Heilberg IP. Ferraz RR, et al. Among authors: heilberg ip. Kidney Int. 2004 Aug;66(2):676-82. doi: 10.1111/j.1523-1755.2004.00790.x. Kidney Int. 2004. PMID: 15253722
Bone disease in idiopathic hypercalciuria.
Heilberg IP, Weisinger JR. Heilberg IP, et al. Curr Opin Nephrol Hypertens. 2006 Jul;15(4):394-402. doi: 10.1097/01.mnh.0000232880.58340.0c. Curr Opin Nephrol Hypertens. 2006. PMID: 16775454
Renal stone disease: Causes, evaluation and medical treatment.
Heilberg IP, Schor N. Heilberg IP, et al. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):823-31. doi: 10.1590/s0004-27302006000400027. Arq Bras Endocrinol Metabol. 2006. PMID: 17117307 Review.
Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients.
Ferraz RR, Marques NC, Froeder L, Menon VB, Siliano PR, Baxmann AC, Heilberg IP. Ferraz RR, et al. Among authors: heilberg ip. Urol Res. 2009 Apr;37(2):95-100. doi: 10.1007/s00240-009-0177-5. Epub 2009 Feb 12. Urol Res. 2009. PMID: 19214493
Effects of calcium supplementation on body weight reduction in overweight calcium stone formers.
Menon VB, Baxmann AC, Froeder L, Martini LA, Heilberg IP. Menon VB, et al. Among authors: heilberg ip. Urol Res. 2009 Jun;37(3):133-9. doi: 10.1007/s00240-009-0187-3. Epub 2009 Mar 27. Urol Res. 2009. PMID: 19326108 Clinical Trial.
Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.
Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Nishiura JL, et al. Among authors: heilberg ip. Clin J Am Soc Nephrol. 2009 Apr;4(4):838-44. doi: 10.2215/CJN.03100608. Epub 2009 Apr 1. Clin J Am Soc Nephrol. 2009. PMID: 19339428 Free PMC article.
81 results
Jump to page
Feedback